Susquehanna International Group’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Sell |
87,623
-3,551
| -4% | -$13.2K | ﹤0.01% | 4926 |
|
|
2025
Q1 | $252K | Buy |
91,174
+55,285
| +154% | +$153K | ﹤0.01% | 5253 |
|
|
2024
Q4 | $199K | Sell |
35,889
-9,989
| -22% | -$55.3K | ﹤0.01% | 5311 |
|
|
2024
Q3 | $383K | Buy |
45,878
+10,048
| +28% | +$83.8K | ﹤0.01% | 3997 |
|
|
2024
Q2 | $244K | Buy |
35,830
+16,087
| +81% | +$110K | ﹤0.01% | 4475 |
|
|
2024
Q1 | $130K | Sell |
19,743
-42,701
| -68% | -$280K | ﹤0.01% | 4908 |
|
|
2023
Q4 | $405K | Buy |
62,444
+23,338
| +60% | +$151K | ﹤0.01% | 4137 |
|
|
2023
Q3 | $197K | Sell |
39,106
-125,745
| -76% | -$632K | ﹤0.01% | 4557 |
|
|
2023
Q2 | $1.44M | Sell |
164,851
-163,177
| -50% | -$1.43M | ﹤0.01% | 2266 |
|
|
2023
Q1 | $3.88M | Buy |
328,028
+289,926
| +761% | +$3.43M | ﹤0.01% | 1275 |
|
|
2022
Q4 | $388K | Buy |
+38,102
| New | +$388K | ﹤0.01% | 3546 |
|